B of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 50.6%

Neg 0% Neu 0% Pos 50.6%

B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Underperform and raises the price target from $28 to $30.